Evaluation of the Effect of Tacrolimus on Periodontitis Induced in Rats

Abstract Objective This study was to investigate the effect of tacrolimus (FK506) on periodontitis induced in rats. Design Periodontal disease was induced in 30 Wistar rats which were then randomly divided into two groups: treatment with a daily injection of 0.9% saline (1 mL/day) and treatment with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of oral biology 2017-08, Vol.80, p.89-94
Hauptverfasser: Moura Penteado, Luiz Alexandre, Lucena, Gilmara Medeiros, Brandão Peixoto, Marcílio Otávio, Barbosa, Thiago Correia, de Souza Leitão Arruda, Ana Carolina, Cimões, Renata
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Abstract Objective This study was to investigate the effect of tacrolimus (FK506) on periodontitis induced in rats. Design Periodontal disease was induced in 30 Wistar rats which were then randomly divided into two groups: treatment with a daily injection of 0.9% saline (1 mL/day) and treatment with a daily injection of FK506. After periods of 10, 15 and 30 days the animals were killed and separate radiographs of the right and left hemimandibles were obtained. One calibrated examiner measured the periodontal bone support (PBS) in the images, after the following treatments: S, saline without ligature; SL, saline with ligature; T, FK506 without ligature; TL, FK506 with ligature. The data were subjected to analysis of variance (ANOVA) and the Tukey test ( p < 0.01). Results The radiographic results were similar at all evaluation time points. The S treatment had a higher PBS averaging at 10, 15 and 30 days, which was statistically significant different compared with the SL treatment and TL treatment, but not significantly different from the T treatment. The SL and TL treatments showed no statistically significant differences between them. Conclusions Tacrolimus used for up to 30 days showed no protective or aggravating effects on alveolar bone loss.
ISSN:0003-9969
1879-1506
DOI:10.1016/j.archoralbio.2017.03.020